ALKYL 4- [4- (5-OXO-2, 3, 5, 11A-TETRAHYD0-5H-PYRR0L0 [2, 1-C] [1, 4] BENZODIAZEPINE-8-YLOXY) -BUTYRYLAMINO]-1H-PYRROLE-2-CARBOXYLATE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF A PROLIFERATIVE DISEASE
    2.
    发明申请
    ALKYL 4- [4- (5-OXO-2, 3, 5, 11A-TETRAHYD0-5H-PYRR0L0 [2, 1-C] [1, 4] BENZODIAZEPINE-8-YLOXY) -BUTYRYLAMINO]-1H-PYRROLE-2-CARBOXYLATE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF A PROLIFERATIVE DISEASE 审中-公开
    亚苄基4- [4-(5-氧代-2,3,5,11-四氢-2H-吲哚-5-基)[2,1-C] [1,4]苯并嗪-5-基) - 丁基]氨基] -1H-吡咯并[ 2-羧酸酯衍生物及相关化合物治疗增殖性疾病

    公开(公告)号:WO2007039752A1

    公开(公告)日:2007-04-12

    申请号:PCT/GB2006/003718

    申请日:2006-10-05

    CPC classification number: C07D487/04

    Abstract: A compound of formula (I); or a salt or solvate thereof, wherein: the dotted line indicates the optional presence of a double bond between C2 and C3; R 2 is selected from -H, -OH, =0, =CH 2 , -CN, -R, OR, halo, =CH-R, O-SO 2 -R, CO 2 R and COR; R 7 is selected from H, R, OH, OR, SH, SR, NH 2 , NHR, NRR', nitro, Me 3 Sn and halo, where R and R' are independently selected from optionally substituted C 1-7 alkyl, C 3-20 heterocyclyl and C 5-20 aryl groups; R 10 and R 11 either together form a double bond, or are selected from H and YR Y , where Y is selected from O, S and NH and R Y is H or C 1-7 alkyl or H and SO x M, where x is 2 or 3, and M is a monovalent pharmaceutically acceptable cation; each X is independently a heteroarylene group; n is from 1 to 6; and R E is C 1-4 alkyl. The compound is useful for the treatment of proliferative diseases.

    Abstract translation: 式(I)化合物; 或其盐或溶剂合物,其中:虚线表示在C2和C3之间任选存在双键; R 2选自-H,-OH,= O,= CH 2,-CN,-R,OR,卤素,= CH-R,O-SO R 2和R 2,R 2和R C; R 7选自H,R,OH,OR,SH,SR,NH 2,NHR,NRR',硝基,Me 3 Sn和卤素,其中R和R'独立地选自任选取代的C 1-7 - 烷基,C 3-20 - 杂环基和C 5-20 - SUB>芳基; R 10和R 11一起形成双键,或选自H和YR Y,其中Y选自O,S 和NH和R Y是H或C 1-7烷基或H和SO x M,其中x是2或3,M 是一价药学上可接受的阳离子; 每个X独立地是亚杂芳基; n为1至6; 并且R E是C 1-4烷基。 该化合物可用于治疗增殖性疾病。

    PYRROLOBENZODIAZEPINES
    3.
    发明申请

    公开(公告)号:WO2005085259A2

    公开(公告)日:2005-09-15

    申请号:PCT/GB2005/000770

    申请日:2005-03-01

    CPC classification number: C07D487/04 Y02P20/55

    Abstract: Compounds and a method of synthesis of compounds of formula (Ia) or (Ib): and salts, solvates, and chemically protected forms thereof, wherein the dotted lines indicate the optional presence of a double bond between C1 and C2 or C2 and C3; R 2 and R 3 are independently selected from -H, =O, =CH 2 , -CN, -R, OR, halo, =CH-R, O-SO 2 -R, CO 2 R and COR; R 10 is a carbamate-based nitrogen protecting group; and R 11 is an oxygen protecting group.

    Abstract translation: 化合物和式(Ia)或(Ib)化合物的合成方法及其盐,溶剂合物和化学保护形式,其中虚线表示C1和C2或C2和C3之间任选存在双键; R 2和R 3独立地选自-H,= O,= CH 2,-CN,-R,OR,卤素,= CH-R,O-SO 2 -R,CO 2 R和COR; R 10是氨基甲酸酯基氮保护基; R 11为氧保护基。

    PIXEL STRUCTURE AND AN ASSOCIATED METHOD OF FABRICATING THE SAME
    5.
    发明申请
    PIXEL STRUCTURE AND AN ASSOCIATED METHOD OF FABRICATING THE SAME 审中-公开
    像素结构及其相关方法

    公开(公告)号:WO2004068454A3

    公开(公告)日:2005-03-24

    申请号:PCT/US2004001067

    申请日:2004-01-14

    CPC classification number: H01L27/14669 G01J5/20

    Abstract: A pixel structure (10), which forms one element of a focal plane array, includes a bolometer having a detector (20) and an insulator (14). The detector (20) is made from a material that absorbs incident thermal radiation and has an electrical resistance that varies in response to changes in the temperature of the material. The insulator (14) has a plurality of serpentine legs disposed completely underneath die detector (20) so that insulator (14) extends between the detector (20) and the substrate (12). And the insulator (14) supports the detector (20) in a spaced-apart relationship with respect to the substrate (12) to thermally isolate the detector (10) from the substrate (12). To further improve the performance of the bolometer, the bolometer includes a resonant layer (18) between the detector (10) and the insulator (14). The resonant layer is disposed such that areas defined between the detector (20) and the resonant layer (18), and between the resonant layer (18) and the insulator (14), form first and second resonant cavities, respectively.

    Abstract translation: 形成焦平面阵列的一个元件的像素结构(10)包括具有检测器(20)和绝缘体(14)的辐射热计。 检测器(20)由吸收入射热辐射的材料制成,并具有响应材料温度变化而变化的电阻。 绝缘体(14)具有完全设置在管芯检测器(20)下方的多个蛇形腿,使得绝缘体(14)在检测器(20)和衬底(12)之间延伸。 并且绝缘体(14)相对于衬底(12)以间隔开的关系支撑检测器(20),以将检测器(10)与衬底(12)热隔离。 为了进一步提高测辐射热谱仪的性能,测辐射热计包括在检测器(10)和绝缘体(14)之间的谐振层(18)。 谐振层被设置成使得限定在检测器(20)和谐振层(18)之间以及谐振层(18)和绝缘体(14)之间的区域分别形成第一和第二谐振腔。

    PYRROLBENZODIAZEPINES
    6.
    发明申请

    公开(公告)号:WO0012508B1

    公开(公告)日:2000-11-02

    申请号:PCT/GB9902838

    申请日:1999-08-27

    CPC classification number: C07D487/04

    Abstract: Compounds of formula (Ia) and (Ib) wherein A is CH2, or a single bond; R2 is selected from: R, OH, OR, CO2H, CO2R, COH, COR, SO2R, CN; R6, R7 and R9 are independently selected from H, R, OH, OR, halo, amino, NHR, nitro, Me3Sn; and R8 is selected from H, R, OH, OR, halo, amino, NHR, nitro, Me3Sn, where R is as defined above, or the compound is a dimer with each monomer being the same or different and being of formula (Ia) or (Ib), where the R8 groups of the monomers form together a bridge having the formula -X-R'-X- linking the monomers, where R' is an alkylene chain containing from 3 to 12 carbon atoms, which chain may be interrupted by one or more hetero-atoms and/or aromatic rings and may contain one or more carbon-carbon double or triple bonds, and each X is independently selected from O, S, or N; except that in a compound of formula (Ia) when A is a single bond, then R2 is not CH=CH(CONH2) or CH=CH(CONMe2). Other related compounds are also disclosed.

    Abstract translation: 式(Ia)和(Ib)的化合物,其中A是CH 2或单键; R2选自:R,OH,OR,CO 2 H,CO 2 R,COH,COR,SO 2 R,CN; R 6,R 7和R 9独立地选自H,R,OH,OR,卤素,氨基,NHR,硝基,Me 3 Sn; 并且R 8选自H,R,OH,OR,卤素,氨基,NHR,硝基,Me 3 Sn,其中R如上所定义,或该化合物是二聚体,每个单体相同或不同,并且具有式 )或(Ib),其中所述单体的R8基团形成具有式-X-R'-X连接单体的桥,其中R'是含有3至12个碳原子的亚烷基链,该链可以 被一个或多个杂原子和/或芳环中断,并且可以含有一个或多个碳 - 碳双键或三键,并且每个X独立地选自O,S或N; 不同之处在于当A为单键时,式(Ia)化合物中,R 2不是CH = CH(CONH 2)或CH = CH(CONMe 2)。 还公开了其它相关化合物。

    PYRROLBENZODIAZEPINES
    7.
    发明申请

    公开(公告)号:WO0012508A3

    公开(公告)日:2000-09-21

    申请号:PCT/GB9902838

    申请日:1999-08-27

    CPC classification number: C07D487/04

    Abstract: Compounds of formula (Ia) and (Ib) wherein A is CH2, or a single bond; R2 is selected from: R, OH, OR, CO2H, CO2R, COH, COR, SO2R, CN; R6, R7 and R9 are independently selected from H, R, OH, OR, halo, amino, NHR, nitro, Me3Sn; and R8 is selected from H, R, OH, OR, halo, amino, NHR, nitro, Me3Sn, where R is as defined above, or the compound is a dimer with each monomer being the same or different and being of formula (Ia) or (Ib), where the R8 groups of the monomers form together a bridge having the formula -X-R'-X- linking the monomers, where R' is an alkylene chain containing from 3 to 12 carbon atoms, which chain may be interrupted by one or more hetero-atoms and/or aromatic rings and may contain one or more carbon-carbon double or triple bonds, and each X is independently selected from O, S, or N; except that in a compound of formula (Ia) when A is a single bond, then R2 is not CH=CH(CONH2) or CH=CH(CONMe2). Other related compounds are also disclosed.

    Abstract translation: 式(Ia)和(Ib)的化合物,其中A是CH 2或单键; R2选自:R,OH,OR,CO2H,CO2R,COH,COR,SO2R,CN; R6,R7和R9独立地选自H,R,OH,OR,卤素,氨基,NHR,硝基,Me3Sn; 和R 8选自H,R,OH,OR,卤素,氨基,NHR,硝基,Me 3 Sn,其中R如上定义,或者该化合物是二聚体,每种单体相同或不同并且具有式 )或(Ib),其中单体的R 8基团一起形成连接单体的具有式-X-R 1 -X-的桥,其中R'是含有3-12个碳原子的亚烷基链,该链可以 被一个或多个杂原子和/或芳环中断,并且可以含有一个或多个碳 - 碳双键或三键,并且每个X独立地选自O,S或N; 除了在式(Ia)的化合物中当A是单键时,则R 2不是CH = CH(CONH 2)或CH = CH(CONMe 2)。 其他相关化合物也被公开。

    SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES
    10.
    发明申请
    SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES 审中-公开
    站点特异性抗体药物联合

    公开(公告)号:WO2016166298A1

    公开(公告)日:2016-10-20

    申请号:PCT/EP2016/058370

    申请日:2016-04-15

    Abstract: Site-specific antibody-drug conjugates are described, in particular conjugates comprising an antibody that binds CD19 and which comprises an amino acid substitution of an interchain cysteine residue by an amino acid that is not cysteine, and pyrrolobenzodiazepines (PBDs) having a labile protecting group in the form of a linker. The site of conjugation, along with modification of the antiobody moiety, allows for improved safety and efficacy of the ADC.

    Abstract translation: 本发明描述了特异性抗体 - 药物偶联物,特别是包含结合CD19的抗体的缀合物,其包含不是半胱氨酸的氨基酸的链间半胱氨酸残基的氨基酸取代和具有不稳定保护基的吡咯并苯并二氮杂(PBD) 以接头的形式。 缀合位点以及抗体部分的修饰允许改善ADC的安全性和功效。

Patent Agency Ranking